Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gynecologic 1Genitourinary 1

Conditions

Lung Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Colorectal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Mouth Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Head and Neck Carcinoma 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Ureteral Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomatitis 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1

Interventions

pembrolizumab 55Carboplatin 33Paclitaxel 24Cyclophosphamide 23Capecitabine 18sacituzumab govitecan 16130-nm albumin-bound paclitaxel 15Specimen Handling 14toripalimab 11Drug Therapy 11Magnetic Resonance Spectroscopy 10Biopsy 10Bevacizumab 10Taxes 9Epirubicin 9durvalumab 8Albumin-Bound Paclitaxel 8olaparib 7camrelizumab 7Gemcitabine 7Doxorubicin 7Docetaxel 7fludarabine 6famitinib 5Nivolumab 5Injections 5atezolizumab 4abemaciclib 4Trastuzumab 4Standard of Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Triple Negative Breast Neoplasms × Practice Guidelines as Topic × Clear all
NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

University of Southern California

Phase NA Recruiting
800 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Thomas Jefferson University

Phase NA Recruiting
80 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡